Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Cancer -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (45)	5/12/2001 6:13:07 PM
From: keokalani'nui	Read Replies (2) \| Respond to of 1840

Miljenko, thank you much. C225 still has some proof to show, but it will be very hard for FDA to turn it down while the company is doing the controlled studies. I bought some May out of the money puts Friday. Maybe it will be better to buy some leap puts instead...in December. I can't figure out if the OSI results are good or bad. Probably neither until they combine with chemo/rad. Always nice to hear from you, especially if it means taking some strong medicine. If you see anything else interesting in asco abstracts/presentations, I would listen.... they are just today avaiable to individual nobodies like me. Wilder

To: Miljenko Zuanic who wrote (45)	5/12/2001 6:21:16 PM
From: keokalani'nui	Respond to of 1840

By the way, I assume you linked to the AltaRex announcement as an example of the right way of proving response duration. Or was this unexpected good news for ALtaRex alone? Wilder

To: Miljenko Zuanic who wrote (45)	5/13/2001 10:27:25 PM
From: Madharry	Read Replies (1) \| Respond to of 1840

for us laypeople- are all of the following terms well defined? 1. failed 2/ partial response 3. stabilized I dont understand what these terms mean? Is it possible for you to post a source for the entire write up? Thank you, I find the results from CEGE very encouraging. It seems more and more clear to me- that many of the gene therapies cannot be given like drugs with uniform dosages that apply to the general population. but if you can help someone with an otherwise incurable and terminal disease. how can it not be approved? genomics and gene therapy will ultimately change the way medicine is practiced the only question is when.